VANCOUVER, BRITISH COLUMBIA / TheNewswire / August 17, 2017 – Exro Technologies Inc. (formerly BioDE Ventures Ltd.) (the “Company”) announces that further to its news release dated July 27, 2017, the Company changed its name to Exro Technologies Inc.

The Company also announces that it intends to complete a non-brokered private placement financing (the "Private Placement") of up to 3,000,000 common shares (the "Common Shares", and each a “Common Share”) at a price of $0.20 per Common Share for gross proceeds of up to CDN$600,000 (the "Proceeds").  The Proceeds will be used for general working capital and capital reserve. The Private Placement is subject to completion of all definitive documentation and filings as required.  The Common Shares issued pursuant to the Private Placement will be subject to a hold period expiring four months plus one day following the date of issuance.  The Company will pay a finders’ fee of 7% cash and 7% brokers’ warrants.

In addition, on August 17, 2017, the Company has issued a total of 901,100 common shares of the Company at $0.20 per share to Intrynsyc Capital Corporation to satisfy the debt obligations in the total amount of $180,220 of the Company and its subsidiary DPM Technologies Inc.  The debt was related to finder’s fees and consulting fees incurred during the last year in the support of the Company’s public listing application.

 

ON BEHALF OF THE BOARD OF DIRECTORS

Mark Godsy

Chief Executive Officer

BioDE Ventures Ltd.

2820 Granville Street

Vancouver, B.C.  V6C 1S4

Tel: (604) 722-9140